VERO BIOTECH INC.

Profile

Company Names

VERO BIOTECH INC.
GENO LLC

Addresses

387 TECHNOLOGY CIR. NW, SUITE 125, ATLANTA, GA 30313

45 FIRST AVENUE, WALTHAM, MA 02451

2941 OXBOW CIRCLE, COCOA, FL 32926

Phone Numbers

678-862-7729
781-466-6530
781-259-8740

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$82,072,228.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-12-08 
$27,265,773.00 
$99,530,958.00 
$72,265,185.00 
Equity 
4
2017-09-01 
$29,941,000.00 
$35,100,000.00 
$5,159,000.00 
Equity 
3
2013-09-20 
$14,738,606.00 
$17,000,000.00 
$2,261,394.00 
Equity 
2
2011-02-17 
$7,990,819.00 
$10,500,000.00 
$2,509,181.00 
Equity 
1
2009-09-02 
$2,136,030.00 
$3,000,000.00 
$863,970.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
ANTINORI 
EXECUTIVE OFFICER
GENO LLC   |  COMANCHE BIOPHARMA CORP.
ERIC 
 
BEDNARSKI 
DIRECTOR
TARSA THERAPEUTICS, INC.   |  AMPLA PHARMACEUTICALS INC   |  SOLX INC   |  PREXA PHARMACEUTICALS INC   |  ACCUVEIN INC.   |  MVM IV LP   |  SOLX EUROPE LTD   |  BIOTHERANOSTICS, INC.   |  VERO BIOTECH INC.   |  NEUROLENS, INC.   |  MDXHEALTH SA   |  MVM VI LP   |  OPTINOSE, INC.   |  MVM J LP
TODD 
 
BRADY 
DIRECTOR
NOVADIGM THERAPEUTICS INC   |  ASMACURE, INC.   |  EVOKE PHARMA INC   |  SEBACIA, INC.   |  ALDEXA THERAPEUTICS, INC.   |  RX GREEN SOLUTIONS LLC   |  ONCOBIOLOGICS, INC.   |  TYROGENEX, INC.   |  THERABRON THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES LLC   |  GENO LLC   |  ALDEYRA THERAPEUTICS, INC.   |  AVIDITY BIOSCIENCES, INC.   |  VERO BIOTECH INC.   |  HYPERFRAME INC.
ROBERTO 
 
COHEN 
EXECUTIVE OFFICER
VERO BIOTECH INC.
KURT 
 
DASSE 
EXECUTIVE OFFICER, DIRECTOR
GENO LLC   |  VADOVATIONS, INC.   |  FLOW FORWARD MEDICAL, INC.
DAVID 
 
FINE 
EXECUTIVE OFFICER, DIRECTOR
GENO LLC
DAVID 
H. 
FINE, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
GENO LLC
BRENT 
 
FURSE 
EXECUTIVE OFFICER, DIRECTOR
GENO LLC
BRENT 
V. 
FURSE 
EXECUTIVE OFFICER, DIRECTOR
VERO BIOTECH INC.
T. 
SCOTT 
JOHNSON, M.D. 
DIRECTOR
GENO LLC
ANTHONY 
 
LOUMIDIS 
EXECUTIVE OFFICER
EUROSITE POWER INC.   |  GENO LLC
THEO 
 
MELAS-KYRIAZI 
DIRECTOR
HELICOS BIOSCIENCES CORP   |  ELEME MEDICAL INC   |  GENO LLC   |  MODERNA LLC
JAMES 
 
O-BRIEN 
EXECUTIVE OFFICER, DIRECTOR
GENO LLC   |  CPI CO-INVESTMENT FUND LP   |  OLSON URBAN HOUSING LLC   |  TRIEA SYSTEMS, INC.   |  HENDERSON INTERNATIONAL ALL CAP EQUITY, LP   |  NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.   |  TRIEA SYSTEMS L.L.C.   |  NOVAQUEST CO-INVESTMENT FUND I, L.P.   |  OC 526 OFFSHORE FUND LTD   |  HENDERSON INTERNATIONAL ACWI EX-US, LP   |  MASTIC COMMODITY FUND LTD.   |  PARLIAMENT INCOME FUND, LLC   |  NAPIER PARK DEEP VALUE CREDIT FUND LP   |  NAPIER PARK DEEP VALUE CREDIT FUND (CAYMAN) LP   |  NAPIER PARK AIR ROLLOVER PROJECT ENTITY LP   |  NAPIER PARK RAIL III PROJECT ENTITY LP   |  NP RAILCAR INVESTMENTS III LP   |  NAPIER PARK DIVERSIFIED ASSETS PROJECT ENTITY I LP   |  NAPIER PARK IAA PROJECT ENTITY LP   |  POLYCARBIN, INC.   |  NAPIER PARK DEEP VALUE CREDIT FUND II LP   |  NAPIER PARK DEEP VALUE CREDIT FUND (CAYMAN) II LP   |  NAPIER PARK EUROPE SPC - CHELTENHAM SP   |  NAPIER PARK ETON FUND GLOBAL FEEDER LTD   |  NAPIER PARK-TX OPPORTUNISTIC CREDIT FUND LP   |  NAPIER PARK ETON FUND US FEEDER LLC   |  VALKYRIE INVESTMENTS INC.   |  NAPIER PARK SELECT FUND LP   |  SOUTHERN ENDEAVOR, LP   |  NAPIER PARK INVESTMENTS II LP   |  GREYSTAR EQUITY PARTNERS XI (892), L.P.   |  GREYSTAR EQUITY PARTNERS XI, L.P.   |  NAPIER PARK CENTRE STREET CLO PARTNERSHIP FUND LP   |  NAPIER PARK VALUE CREDIT FUND I LP   |  NAPIER PARK VALUE CREDIT FUND (CAYMAN) I LP   |  LQR HOUSE INC.   |  NAPIER PARK CONCORDE US FEEDER LP   |  GEP XII SIDECAR I, LP   |  GREYSTAR EQUITY PARTNERS XII, LP   |  NAPIER PARK EUROPE SPC - CONCORDE SP
VINZENZ 
 
PLOERER 
DIRECTOR
CLARASSANCE, INC.   |  THERABRON THERAPEUTICS, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  TYROGENEX, INC.   |  ANTIVA BIOSCIENCES, INC.   |  GENO LLC
ROBERT 
 
ROSCIGNO 
EXECUTIVE OFFICER
GENO LLC   |  LIQUIDIA TECHNOLOGIES INC
DANIEL 
 
SALAZAR 
DIRECTOR
VERO BIOTECH INC.   |  MILKMEN HOLDINGS LLC
DAN 
 
SALAZAR, PH.D. 
DIRECTOR
GENO LLC
STEVEN 
 
SHULMAN 
DIRECTOR, EXECUTIVE OFFICER
GENO LLC   |  BROADLANE HOLDINGS LLC   |  AMQ HOLDINGS, LLC   |  PAGER, INC.
TOD 
 
SHULTZ 
EXECUTIVE OFFICER
GENO LLC
THIAGO 
 
TAVARES 
DIRECTOR
VERO BIOTECH INC.
SHASHA 
 
ZOU 
EXECUTIVE OFFICER
VERO BIOTECH INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-12-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-12-08 
2017-09-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-09-01 
2013-10-18
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-09-20 
2013-10-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-09-20 
2011-12-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-17 
2009-09-14
D
Link
PHARMACEUTICALS 
 
NOT APPLICABLE 
Equity 
2009-09-02 
2009-09-14
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2009-09-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#